PL3076996T3 - Szczepionka przeciwko cirkowirusowi świń typu 2 - Google Patents
Szczepionka przeciwko cirkowirusowi świń typu 2Info
- Publication number
- PL3076996T3 PL3076996T3 PL14805617T PL14805617T PL3076996T3 PL 3076996 T3 PL3076996 T3 PL 3076996T3 PL 14805617 T PL14805617 T PL 14805617T PL 14805617 T PL14805617 T PL 14805617T PL 3076996 T3 PL3076996 T3 PL 3076996T3
- Authority
- PL
- Poland
- Prior art keywords
- virus type
- vaccine against
- against porcine
- circo virus
- porcine circo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13195515 | 2013-12-03 | ||
PCT/EP2014/076224 WO2015082458A1 (en) | 2013-12-03 | 2014-12-02 | Vaccine against porcine circo virus type 2 |
EP14805617.9A EP3076996B1 (en) | 2013-12-03 | 2014-12-02 | Vaccine against porcine circo virus type 2 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3076996T3 true PL3076996T3 (pl) | 2020-05-18 |
Family
ID=49680926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14805617T PL3076996T3 (pl) | 2013-12-03 | 2014-12-02 | Szczepionka przeciwko cirkowirusowi świń typu 2 |
Country Status (13)
Country | Link |
---|---|
US (1) | US10130698B2 (pl) |
EP (1) | EP3076996B1 (pl) |
JP (1) | JP6605469B2 (pl) |
KR (1) | KR20160093047A (pl) |
CN (2) | CN105848675A (pl) |
BR (1) | BR112016012435A8 (pl) |
CA (1) | CA2931137C (pl) |
DK (1) | DK3076996T3 (pl) |
ES (1) | ES2771899T3 (pl) |
MX (1) | MX369039B (pl) |
PL (1) | PL3076996T3 (pl) |
RU (1) | RU2712155C2 (pl) |
WO (1) | WO2015082458A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105848675A (zh) | 2013-12-03 | 2016-08-10 | 英特维特国际股份有限公司 | 抗猪圆环病毒2型的疫苗 |
RU2018118175A (ru) * | 2015-10-22 | 2019-11-25 | Интервет Интернэшнл Б.В. | Вакцина для защиты mda-позитивного животного от расстройства, возникающего в результате инфекции, вызванной lawsonia intracellularis |
US11654191B2 (en) | 2016-03-23 | 2023-05-23 | Intervet Inc. | Vaccine for intradermal application against PCV2 and PRRS virus infection |
CA3058281A1 (en) * | 2017-04-13 | 2018-10-18 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2236574A1 (en) | 1995-11-30 | 1997-06-05 | Daratech Pty. Ltd. | Therapeutic and diagnostic compositions |
FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
MXPA06000942A (es) | 2003-07-24 | 2006-03-30 | Merial Ltd | Nuevas formulaciones de vacunas. |
BRPI0507017A (pt) | 2004-01-22 | 2007-06-05 | Intervet Int Bv | ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7691368B2 (en) * | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
RU2389506C2 (ru) * | 2005-09-09 | 2010-05-20 | Интервет Интернэшнл Б.В. | Вакцина против рсv-2 |
CN104383526B (zh) | 2005-12-29 | 2018-09-18 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2免疫原性组合物用于减轻猪临床症状的用途 |
EP2101815A4 (en) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS |
US8865183B2 (en) * | 2006-12-15 | 2014-10-21 | Boehringer Ingelheim Vetmedica, Inc. | Treatment of pigs with PCV2 antigent |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
MX2010007815A (es) * | 2008-01-23 | 2010-08-10 | Boehringer Ingelheim Vetmed | Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo. |
TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌(Lawsonia intracellularis)用疫苗 |
TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
CN105848675A (zh) | 2013-12-03 | 2016-08-10 | 英特维特国际股份有限公司 | 抗猪圆环病毒2型的疫苗 |
EP3076995B1 (en) | 2013-12-03 | 2020-03-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
-
2014
- 2014-12-02 CN CN201480066507.5A patent/CN105848675A/zh active Pending
- 2014-12-02 US US15/038,765 patent/US10130698B2/en active Active
- 2014-12-02 RU RU2016126392A patent/RU2712155C2/ru active
- 2014-12-02 WO PCT/EP2014/076224 patent/WO2015082458A1/en active Application Filing
- 2014-12-02 ES ES14805617T patent/ES2771899T3/es active Active
- 2014-12-02 BR BR112016012435A patent/BR112016012435A8/pt not_active Application Discontinuation
- 2014-12-02 MX MX2016007224A patent/MX369039B/es active IP Right Grant
- 2014-12-02 KR KR1020167017419A patent/KR20160093047A/ko not_active Application Discontinuation
- 2014-12-02 JP JP2016535652A patent/JP6605469B2/ja active Active
- 2014-12-02 CN CN201910822557.6A patent/CN110354258A/zh active Pending
- 2014-12-02 CA CA2931137A patent/CA2931137C/en active Active
- 2014-12-02 PL PL14805617T patent/PL3076996T3/pl unknown
- 2014-12-02 DK DK14805617.9T patent/DK3076996T3/da active
- 2014-12-02 EP EP14805617.9A patent/EP3076996B1/en not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
RU2712155C2 (ru) | 2020-01-24 |
KR20160093047A (ko) | 2016-08-05 |
MX2016007224A (es) | 2016-07-21 |
JP2017501984A (ja) | 2017-01-19 |
JP6605469B2 (ja) | 2019-11-13 |
MX369039B (es) | 2019-10-25 |
US10130698B2 (en) | 2018-11-20 |
WO2015082458A1 (en) | 2015-06-11 |
CA2931137C (en) | 2023-03-14 |
CN105848675A (zh) | 2016-08-10 |
ES2771899T3 (es) | 2020-07-07 |
CN110354258A (zh) | 2019-10-22 |
BR112016012435A2 (pt) | 2017-08-08 |
DK3076996T3 (en) | 2020-03-09 |
CA2931137A1 (en) | 2015-06-11 |
BR112016012435A8 (pt) | 2018-01-30 |
US20170157236A1 (en) | 2017-06-08 |
EP3076996B1 (en) | 2020-01-15 |
EP3076996A1 (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276210B1 (en) | Mers-cov vaccine | |
IL279395A (en) | A vaccine | |
SG11201507883SA (en) | Wt1-antigen peptide conjugate vaccine | |
PT2806891T (pt) | Vacinas baseadas no vírus parainfluenza 5 | |
HK1218872A1 (zh) | 乙型肝炎疫苗 | |
GB201321242D0 (en) | Immunogenic compound | |
GB201304837D0 (en) | Implant trialling | |
IL241271A0 (en) | Pertussis vaccine | |
GB201301085D0 (en) | Glycoconjugate Vaccine | |
GB201304835D0 (en) | Implant trialling | |
EP3054972A4 (en) | VACCINES HAVING ADJUVANT INTERLEUKIN-33 | |
HK1218877A1 (zh) | 粘膜疫苗組合物 | |
SG11201510617WA (en) | Methods and compositions for dengue virus vaccines | |
SG11201505930TA (en) | Porcine parvovirus 5b, methods of use and vaccine | |
PL3076996T3 (pl) | Szczepionka przeciwko cirkowirusowi świń typu 2 | |
HK1217206A1 (zh) | 疫苗 | |
HK1219054A1 (zh) | 粘膜疫苗組合物 | |
GB201301119D0 (en) | Viral vaccines | |
HK1219904A1 (zh) | 針對多種登革病毒亞型的新穎疫苗 | |
SG11201507455WA (en) | Hepatitis b virus vaccines | |
PL2986639T3 (pl) | Kompozycja o zmniejszonej immunogenności | |
ZA201506581B (en) | Acellular pertussis vaccine | |
GB201314063D0 (en) | Virus | |
GB201306812D0 (en) | Virus | |
GB201320646D0 (en) | Vaccine |